
浏览全部资源
扫码关注微信
济宁医学院附属医院
纸质出版日期:2020,
网络出版日期:2020-12-1,
扫 描 看 全 文
强光峰, 赵静, 孟兰兰, 等. 肺部超声在动态观察肺表面活性物质治疗早产儿呼吸窘迫综合征的应用价值[J]. 临床超声医学杂志, 2020,22(11).
The value of lung ultrasound to observe pulmonary surfactant dynamically in the treatment of respiratory distress syndrome in preterm neonates[J]. Journal of Clinical Ultrasound in Medicine, 2020,22(11).
目的 探讨肺部超声动态观察肺表面活性物质(pulmonary surfactant
PS)治疗早产儿呼吸窘迫综合征(respiratory distress syndrome
RDS)的应用价值。方法 前瞻性选取2018年6月-2018年12月由济宁医学院附属医院产科转至新生儿重症监护病房的30例RDS早产儿
分别在PS使用前及PS使用后6h、12h、18h、24h五个时间点进行肺部超声检查并评分
观察在PS使用前后不同时间肺部超声及其评分的变化规律。结果 PS使用前
16例(53%)患儿肺部超声中表现为弥漫白肺
14例(47%)肺泡间质综合征
11例(37%)胸膜下肺实变;PS使用后6h
3例(10%)表现为弥漫白肺
2例(6.7%)可见胸膜下肺实变
较PS使用前明显好转
差异具有统计学意义(c2分别为11.09、6.29
P分别为0.001、0.012)。在PS使用后12h、18h、24h
所有患儿肺部超声均未见弥漫白肺、肺实变
与PS使用前比较
差异具有统计学意义(c2=19.18
P<0.001)
但相比PS使用后6h
差异无统计学意义(c2=1.40
P=0.24)。进一步使用肺部超声评分进行分析
PS使用后6h、12h、18h、24h超声评分分别为19.3±4.0、17.4±3.9、17.6±4.0、17.9±4.2
较PS使用前超声评分22.3±2.6
差异具有统计学意义(P均<0.05)
而PS使用后6h、12h、18h、24h之间的超声评分差异不大
无统计学意义(P均>0.05)。结论 肺部超声可以动态观察PS对RDS的治疗效果
在使用PS后6h
肺部超声即可以发现肺部病变较前明显好转。
Objective To investigate the value of lung ultrasound in the dynamic observation of pulmonary surfactant (PS) in the treatment of respiratory distress syndrome(RDS) in premature infants. Methods Thirty preterm infants diagnosed with RDS were transferred from our obstetrics department to the neonatal intensive care unit from June to December 2018 prospectively. Lung ultrasound was performed and scored before and after PS use at 6h
12h
18h
and 24h. The aim was to observe the effect of PS on preterm neonates with RDS and the dynamic change of lung ultrasound at different times. Results Before the use of PS
16 cases (53%) of the children showed bilateral white lung in lung ultrasound
14 cases (47%) of alveolar interstitial syndrome
and 11 cases (37%) of subpleural lung consolidation; after 6 hours of PS use
3 cases (10%) showed bilateral white lung
and 2 cases (6.7%) showed subpleural lung consolidation
which was significantly better than that before PS use
and the difference was statistically significant (c2 were 11.09 and 6.29
respectively; P was 0.001 and 0.012
respectively). At 12h
18h
and 24h after PS use
bilateral white lung and lung consolidation were not seen in the lung ultrasound of all preterm neonates with RDS. Compared with that before PS
the difference was statistically significant (c2 = 19.18
P <0.001)
but the difference was not statistically significant compared with that at 6 hours after PS use (c2 = 1.40
P = 0.24). Further
lung ultrasound score was used for analysis. The lung ultrasound score at 6h
12h
18h
and 24h after PS was 19.3 ± 4.0
17.4 ± 3.9
17.6 ± 4.0
and 17.9 ± 4.2
respectively
which was lower than that before PS use. And the difference was statistically significant (all P< 0.05). However
the differences of lung ultrasound score at 6h
12h
18h
and 24h after PS use were not statistically significant (all P> 0.05). Conclusion Lung ultrasound can dynamically evaluate the effect of PS in the treatment of preterm neonates with RDS. After 6 hours of PS
the pulmonary condition can be improved significantly.
肺部超声早产儿呼吸窘迫综合征肺表面活性物质
Lung ultrasoundPreterm neonatesPulmonary surfactantRespiratory distress syndrome
0
浏览量
571
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621